Rmpl Pharma LLP
Indian Pharmaceutical Exporter ยท Advanced Oncology Specialist ยท $438.6K Total Trade ยท DGFT Verified
Rmpl Pharma LLP is an Indian pharmaceutical exporter with a total trade value of $438.6K across 13 products in 3 therapeutic categories. Based on 326 verified export shipments from Indian Customs (DGFT) records, Rmpl Pharma LLP is the #1 Indian exporter in 2 products including Cladribine, Levodopa Carbidopa. Top exports include Lenalidomide ($145.7K), Rituximab ($92.7K), Daratumumab ($55.0K).
Rmpl Pharma LLP โ Export Portfolio & Destination Treemap

Who is Rmpl Pharma LLP? โ Company Overview & Market Position
RMPL Pharma LLP, established on May 16, 2015, is a Mumbai-based pharmaceutical exporter specializing in oncology and specialized products. As a part of the Royal Group of companies, which dates back to 1944, RMPL Pharma has built a reputation as a leading merchant exporter in India. The company is registered under the Corporate Identification Number (CIN) AAD-9570. While specific revenue figures are not publicly disclosed, RMPL Pharma operates with a total obligation of contribution of โน98,000. The firm employs a dedicated team of 23 professionals, including designated partners Mahendra Mukundlal Gandhi and Asan Mohideen Nagoormeeran Sheik Packeer. Their official website is www.rmplpharma.com.